Clinical Trial Update: Analysis of Host Genetic Factors in the Occurrence of Anemia and on the Virological Response to a Peg-interferon/Ribavirin Therapy in HIV-HCV Co-infected Patients [NA]

View source ↗

Summary

This completed clinical trial analyzed host genetic factors to understand anemia risk and virological response to Peg-interferon plus ribavirin in HIV-HCV co-in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis C

Drugs mentioned

• Copegus (ribavirin)
• Pegasys (pegylated interferon alfa-2a)

Snippet

Sponsor: Assistance Publique Hopitaux De Marseille | Conditions: HIV-HCV Co-infected Patients | NA | Status: COMPLETED